Trade

with

Prana Biotechnology Ltd
(NASDAQ: PRAN)
AdChoices
1.98
+0.04
+2.06%
After Hours :
-
-
-

Open

1.98

Previous Close

1.94

Volume (Avg)

42.44k (842.44k)

Day's Range

1.93-1.98

52Wk Range

1.47-13.29

Market Cap.

82.05M

Dividend Rate ( Yield )

-

Beta

0.63

Shares Outstanding

41.65M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 4.07M

    • Net Income

    • -6.84M

    • Market Cap.

    • 82.05M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -285.73

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.63

    • Forward P/E

    • -

    • Price/Sales

    • 21.46

    • Price/Book Value

    • 4.73

    • Price/Cash flow

    • -7.91

      • EBITDA

      • -6.80M

      • Return on Capital %

      • -60.98

      • Return on Equity %

      • -77.82

      • Return on Assets %

      • -60.98

      • Book Value/Share

      • 0.37

      • Shares Outstanding

      • 41.65M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 4.68

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.04

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -12.30

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 56.64

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -285.73

            • 39.38

            • Net Profit Margin

            • -285.73

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1,706.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -1,706.60

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 5.16

              • 2.92

              • Quick Ratio

              • 5.13

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.24

              • 2.21

              • Book Value/Share

              • 0.42

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.52

                • 196.08

                • P/E Ratio 5-Year High

                • -50.76

                • 634.30

                • P/E Ratio 5-Year Low

                • -3.90

                • 124.82

                • Price/Sales Ratio

                • 21.51

                • 9.12

                • Price/Book Value

                • 4.73

                • 8.26

                • Price/Cash Flow Ratio

                • -7.91

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -77.82

                        (-97.70)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -60.98

                        (-77.50)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -77.82

                        (-96.00)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.21

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -6.85M
                      Operating Margin
                      -168.17
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -7.91
                      Ownership

                      Institutional Ownership

                      2.35%

                      Top 10 Institutions

                      2.03%

                      Mutual Fund Ownership

                      0.01%

                      Float

                      -

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® NASDAQ Composite Index® Fund

                      •  

                        3,293

                      • 0.00

                      • 0.01

                      • Fidelity® Nasdaq Composite Tr Stk Fund

                      •  

                        1,335

                      • 9.52

                      • 0.00

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Susquehanna Financial Group, LLLP

                      •  

                        241,750

                      • +10.98%

                      • 0.58

                      • Garrison Bradford & Associates Inc

                      •  

                        129,342

                      • -4.08%

                      • 0.31

                      • JANE STREET GROUP, LLC

                      •  

                        128,660

                      • +102.13%

                      • 0.31

                      • Columbia Asset Management, L.L.C.

                      •  

                        64,150

                      • +5.34%

                      • 0.15

                      • Morgan Stanley & Co Inc

                      •  

                        63,855

                      • +38.36%

                      • 0.15

                      • Group One Trading, LP

                      •  

                        58,238

                      • -21.19%

                      • 0.14

                      • Columbia Management Company

                      •  

                        39,000

                      • -18.75%

                      • 0.09

                      • Goldman, Sachs & Co.

                      •  

                        36,096

                      • -20.27%

                      • 0.09

                      • Citadel Advisors Llc

                      •  

                        31,687

                      • -73.49%

                      • 0.08

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Prana Biotechnology Ltd was incorporated on November 11, 1997. The Company is a development stage company at an early stage in the development of its pharmaceutical products. The Company’s activities include research into Alzheimer ’s disease and other major age-related degenerative disorders.

                      Key People

                      Geoffrey P. Kempler

                      CEO/Chairman of the Board/Director

                      Richard Revelins

                      CFO/Secretary

                      Brian D. Meltzer

                      Director

                      George W. Mihaly

                      Director

                      Peter Marks

                      Director

                      • Prana Biotechnology Ltd

                      • 369 Royal Parade

                      • Parkville, VIC 3052

                      • AUS.Map

                      • Phone: +61 393494906

                      • Fax: +61 393480377

                      • pranabio.com

                      Incorporated

                      1997

                      Employees

                      9

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: